Dermafence
Burn Treatment Technology
StartupDermafence is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2017. Burn Treatment Technology. The company has raised a total of $20K across 3 funding rounds, currently at the Seed stage. Dermafence was founded by Dr. Shulamit Richter Dayan. Key investors include MassChallenge. The company has 1-10 employees. Core technologies: Materials & Substances.
With $20K in total funding, Dermafence is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2C/B2B2C business model. Product stage: R&D. The company holds 1 patent.
- StageSeed
- ProductR&D
- ModelB2C, B2B2C
- Employees1-10
- HQJerusalem
- DistrictJerusalem District
- Last Round$10K
- MassChallengeLead
Dr. Shulamit Richter DayanFounder & CEO
What does Dermafence do?
Dermafence has developed a proprietary technology for the treatment of burns. The company's technology is based on a GRAS formulation with a novel mechanism of action designed to bar energy from progressing to the deeper layers of the skin. Dermafence has developed a first aid burn formulation that restores and protects epidermal "skin barrier" function following exposure to insults that introduce energy to the skin.
How much funding has Dermafence raised?
Dermafence has raised $20K in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include MassChallenge.
Who founded Dermafence?
Dermafence was founded in 2017 by Dr. Shulamit Richter Dayan (Founder & CEO).
What sector is Dermafence in?
Dermafence operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Materials & Substances. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Dermafence located?
Dermafence is based in Professor Racah Street, Jerusalem, Israel, Jerusalem District.